机构ID,机构名称,公告日期,截止日期,报告年度,合并类型,报表来源,货币资金（元）,以公允价值计量且其变动计入当期损益的金融资产,应收票据,应收账款,预付款项,其他应收款,应收关联公司款,应收利息,应收股利,存货,其中：消耗性生物资产,一年内到期的非流动资产,其他流动资产,流动资产合计,可供出售金融资产,持有至到期投资,长期应收款,长期股权投资,投资性房地产,固定资产,在建工程,工程物资,固定资产清理,生产性生物资产,油气资产,无形资产,开发支出,商誉,长期待摊费用,递延所得税资产,其他非流动资产,非流动资产合计,资产总计,短期借款,以公允价值计量且其变动计入当期损益的金融负债,应付票据,应付账款,预收款项,应付职工薪酬,应交税费,应付利息,应付股利,其他应付款,应付关联公司款,一年内到期的非流动负债,其他流动负债,流动负债合计,长期借款,应付债券,长期应付款,专项应付款,预计负债,递延所得税负债,其他非流动负债,非流动负债合计,负债合计,实收资本（或股本）,资本公积,盈余公积,专项储备,减：库存股,一般风险准备,未分配利润,归属于母公司所有者权益,少数股东权益,外币报表折算价差,非正常经营项目收益调整,所有者权益（或股东权益）合计,负债和所有者（或股东权益）合计,其他综合收益,递延收益-非流动负债,结算备付金,拆出资金,发放贷款及垫款-流动资产,衍生金融资产,应收保费,应收分保账款,应收分保合同准备金,买入返售金融资产,划分为持有待售的资产,发放贷款及垫款-非流动资产,向中央银行借款,吸收存款及同业存放,拆入资金,衍生金融负债,卖出回购金融资产款,应付手续费及佣金,应付分保账款,保险合同准备金,代理买卖证券款,代理承销证券款,划分为持有待售的负债,预计负债-流动负债,递延收益-流动负债,其中：优先股-非流动负债,永续债-非流动负债,长期应付职工薪酬,其他权益工具,其中：优先股-所有者权益,永续债-所有者权益
2826,易明医药,2016-11-14,2016-06-30,2016-06-30,合并本期,招募说明书,57955506.19,,18069393.66,64878850.03,18833065.77,25781635.43,,,,40787016.36,,,3986546.89,230292014.33,140000.0,,,,,137846505.7,1453680.0,,,,,25592957.21,12250000.0,7667186.44,421756.57,5834075.22,714318.86,191920480.0,422212494.33,10000000.0,,,18227209.99,27954528.42,2044612.44,5637174.2,78216.67,,34576912.83,,10000000.0,0.0,108518654.55,39000000.0,,,250000.0,,,0.0,40865000.0,149383654.55,142290000.0,19713566.38,6245735.85,,,,104579537.55,272828839.78,,,0.0,272828839.78,422212494.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2826,易明医药,2016-11-14,2016-09-30,2016-09-30,合并本期,招募说明书,,,,,,,,,,,,,0.0,225277600.0,,,,,,,,,,,,,,,,,0.0,,416924300.0,,,,,,,,,,,,,0.0,92016200.0,,,,,,,0.0,,133088700.0,,,,,,,,283835600.0,,,0.0,283835600.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-03-30,2016-12-31,2016-12-31,合并本期,定期报告,281321873.11,,13650806.99,78845334.61,21298001.95,19625830.19,,,,36676748.32,,,591860.47,452010455.64,,,,,,137856575.14,1956170.0,,,,,25265792.23,13860198.05,7667186.44,272769.49,6290290.08,1181416.2,194350397.63,646360853.27,10000000.0,,,14299972.96,21218334.88,2013863.78,5182080.18,,,36181055.6,,,,88895307.4,,,,500000.0,,,,2030000.0,90925307.4,189720000.0,224109331.45,11474767.91,,,,130131446.51,555435545.87,,,,555435545.87,646360853.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-04-24,2017-03-31,2017-03-31,合并本期,定期报告,163937366.51,,1054250.0,74474482.7,27071976.93,20923838.52,,,,41576128.92,,,100698495.36,429736538.94,,,,,,143374580.49,1988187.74,,,,,24942295.21,15307703.25,7667186.44,694092.99,6310635.22,24298391.66,224583073.0,654319611.94,10000000.0,,,8502809.53,24064786.91,2422761.08,6373598.74,,,39976920.47,,,,91340876.73,,,,500000.0,,,,1987500.0,93328376.73,189720000.0,224109331.45,11474767.91,,,,135687135.85,560991235.21,,,,560991235.21,654319611.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-08-19,2017-06-30,2017-06-30,合并本期,定期报告,159251372.86,,16815793.4,81566108.99,27660302.66,6823432.74,,,,41389966.01,,,100700454.28,434207430.94,,,,,,142715589.13,4038187.74,,,,,24611469.2,17265632.17,7667186.44,614876.85,5979966.69,29159953.76,232052861.98,666260292.92,10000000.0,,,8946437.06,16680134.31,2284832.99,7612796.71,,,52604007.15,,,,98128208.22,,,,500000.0,,,,2748250.0,100876458.22,189720000.0,224109331.45,11474767.91,,,,140079735.34,565383834.7,,,,565383834.7,666260292.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2826,易明医药,2017-10-24,2017-09-30,2017-09-30,合并本期,定期报告,123698414.5,,10860473.2,75228169.25,38146668.43,28323693.57,,,,41187610.0,,,121149968.94,438594997.89,,,,,,165343456.42,4038187.74,,,,,24532677.6,18471114.04,7667186.44,1617755.31,6046377.51,4882952.03,232599707.09,671194704.98,10000000.0,,,8595006.14,16618504.37,1512694.99,4445274.57,,,49766772.15,,,,90938252.22,,,,500000.0,,,,2685499.93,93623752.15,189720000.0,224109331.45,11474767.91,,,,152266853.47,577570952.83,,,,577570952.83,671194704.98,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
